González-Moreno EI, García-Compean D, González-González JA, Maldonado-Garza HJ

Language: English
References: 4
Page: 801-802
PDF size: 109.71 Kb.

Text Extraction

Dear editor:

We read with great interest the article by Fukuda, et al.1 who found in a population-based retrospective cohort study among 4,629 participants that non-overweight individuals with non-alcoholic fatty liver disease (NAFLD) had a high risk of incident type 2 diabetes mellitus (T2DM). In developed countries NAFLD is the leading cause of chronic liver disease (CLD), as data showed that between 1988 to 1994 NAFLD accounted for 46.8% of all CLD, and between 2005 to 2008 it accounted for 75.1%.

REFERENCES

1. Fukuda T, Hamaguchi M, Kojima T, Hashimoto Y, Ohbora A, Kato T, Nakamura N, et al. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in nonoverweight individuals. Liver Int 2016; 36: 275-83.

2. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9: 524-30.e1; quiz e60.

3. Koehler EM, Plompen EP, Schouten JN, Hansen BE, Darwish Murad S, Taimr P, Leebeek FW, et al. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study. Hepatology 2016; 63: 138-47.

4. Manchanayake J, Chitturi S, Nolan C, Farrell GC. Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2011; 26: 510-6.